1. Cost Effectiveness of Rituximab for Non-Hodgkin’s Lymphoma

   • Philipp Wolfgang Peter Auweiler
   • Dirk Müller
   • Andreas Gerber

   Systematic Review 23 December 2012 Pages: 537 - 549

   

2. Economic Evaluation of Smoking-Cessation Therapies

   • Kristian Bolin

   Systematic Review 23 December 2012 Pages: 551 - 564

   

3. Hospital Reimbursement Price Cap for Cancer Drugs

   • Albane Degrassat-Théas
   • M. Bensadon
   • P. Paubel

   Original Research Article 23 December 2012 Pages: 565 - 573

   

4. Cost Utility of Tumour Necrosis Factor-α Inhibitors for Rheumatoid Arthritis

   • Christine M. Nguyen
   • Mark Bounthavong
   • Anthony P. Morreale

   Original Research Article 23 December 2012 Pages: 575 - 593

   

5. Duloxetine Use in Chronic Low Back Pain

   • Jasmina I. Ivanova
   • Howard G. Birnbaum
   • Ralph W. Swindle

   Original Research Article 23 December 2012 Pages: 595 - 609

   

6. Quetiapine

   • Greg L. Plosker

   Adis Pharmacoeconomic Drug Evaluation 06 January 2012 Pages: 611 - 631